Florida Senate - 2017                                    SB 1618
       
       
        
       By Senator Artiles
       
       
       
       
       
       40-01109-17                                           20171618__
    1                        A bill to be entitled                      
    2         An act relating to controlled substances; amending s.
    3         893.03, F.S.; adding CBD (Cannabidiol) to the Schedule
    4         I list of controlled substances; providing an
    5         effective date.
    6          
    7  Be It Enacted by the Legislature of the State of Florida:
    8  
    9         Section 1. Paragraph (c) of subsection (1) of section
   10  893.03, Florida Statutes, is amended to read:
   11         893.03 Standards and schedules.—The substances enumerated
   12  in this section are controlled by this chapter. The controlled
   13  substances listed or to be listed in Schedules I, II, III, IV,
   14  and V are included by whatever official, common, usual,
   15  chemical, trade name, or class designated. The provisions of
   16  this section shall not be construed to include within any of the
   17  schedules contained in this section any excluded drugs listed
   18  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   19  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   20  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   21  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   22  Anabolic Steroid Products.”
   23         (1) SCHEDULE I.—A substance in Schedule I has a high
   24  potential for abuse and has no currently accepted medical use in
   25  treatment in the United States and in its use under medical
   26  supervision does not meet accepted safety standards. The
   27  following substances are controlled in Schedule I:
   28         (c) Unless specifically excepted or unless listed in
   29  another schedule, any material, compound, mixture, or
   30  preparation that contains any quantity of the following
   31  hallucinogenic substances or that contains any of their salts,
   32  isomers, including optical, positional, or geometric isomers,
   33  homologues, nitrogen-heterocyclic analogs, esters, ethers, and
   34  salts of isomers, homologues, nitrogen-heterocyclic analogs,
   35  esters, or ethers, if the existence of such salts, isomers, and
   36  salts of isomers is possible within the specific chemical
   37  designation or class description:
   38         1. Alpha-Ethyltryptamine.
   39         2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
   40  oxazoline).
   41         3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
   42         4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
   43         5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
   44         6. Bufotenine.
   45         7. Cannabis.
   46         8. Cathinone.
   47         9. DET (Diethyltryptamine).
   48         10. 2,5-Dimethoxyamphetamine.
   49         11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
   50         12. DMT (Dimethyltryptamine).
   51         13. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
   52  of phencyclidine).
   53         14. JB-318 (N-Ethyl-3-piperidyl benzilate).
   54         15. N-Ethylamphetamine.
   55         16. Fenethylline.
   56         17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
   57         18. Ibogaine.
   58         19. LSD (Lysergic acid diethylamide).
   59         20. Mescaline.
   60         21. Methcathinone.
   61         22. 5-Methoxy-3,4-methylenedioxyamphetamine.
   62         23. PMA (4-Methoxyamphetamine).
   63         24. PMMA (4-Methoxymethamphetamine).
   64         25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
   65         26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
   66         27. MDA (3,4-Methylenedioxyamphetamine).
   67         28. JB-336 (N-Methyl-3-piperidyl benzilate).
   68         29. N,N-Dimethylamphetamine.
   69         30. Parahexyl.
   70         31. Peyote.
   71         32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
   72  analog of phencyclidine).
   73         33. Psilocybin.
   74         34. Psilocyn.
   75         35. Salvia divinorum, except for any drug product approved
   76  by the United States Food and Drug Administration which contains
   77  Salvia divinorum or its isomers, esters, ethers, salts, and
   78  salts of isomers, esters, and ethers, if the existence of such
   79  isomers, esters, ethers, and salts is possible within the
   80  specific chemical designation.
   81         36. Salvinorin A, except for any drug product approved by
   82  the United States Food and Drug Administration which contains
   83  Salvinorin A or its isomers, esters, ethers, salts, and salts of
   84  isomers, esters, and ethers, if the existence of such isomers,
   85  esters, ethers, and salts is possible within the specific
   86  chemical designation.
   87         37. Xylazine.
   88         38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
   89  (Thiophene analog of phencyclidine).
   90         39. 3,4,5-Trimethoxyamphetamine.
   91         40. Methylone (3,4-Methylenedioxymethcathinone).
   92         41. MDPV (3,4-Methylenedioxypyrovalerone).
   93         42. Methylmethcathinone.
   94         43. Methoxymethcathinone.
   95         44. Fluoromethcathinone.
   96         45. Methylethcathinone.
   97         46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
   98  yl)phenol) and its dimethyloctyl (C8) homologue.
   99         47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
  100  methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
  101         48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  102         49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  103         50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  104  naphthoyl)indole).
  105         51. BZP (Benzylpiperazine).
  106         52. Fluorophenylpiperazine.
  107         53. Methylphenylpiperazine.
  108         54. Chlorophenylpiperazine.
  109         55. Methoxyphenylpiperazine.
  110         56. DBZP (1,4-Dibenzylpiperazine).
  111         57. TFMPP (Trifluoromethylphenylpiperazine).
  112         58. MBDB (Methylbenzodioxolylbutanamine) or (3,4
  113  Methylenedioxy-N-methylbutanamine).
  114         59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  115         60. 5-Hydroxy-N-methyltryptamine.
  116         61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  117         62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  118         63. Methyltryptamine.
  119         64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  120         65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  121         66. Tyramine (4-Hydroxyphenethylamine).
  122         67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  123         68. DiPT (N,N-Diisopropyltryptamine).
  124         69. DPT (N,N-Dipropyltryptamine).
  125         70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  126         71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  127         72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  128         73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  129         74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  130         75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  131         76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  132         77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  133         78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  134         79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  135         80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  136         81. Butylone (3,4-Methylenedioxy-alpha
  137  methylaminobutyrophenone).
  138         82. Ethcathinone.
  139         83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
  140         84. Naphyrone (Naphthylpyrovalerone).
  141         85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
  142         86. 3,4-Methylenedioxy-N,N-diethylcathinone.
  143         87. 3,4-Methylenedioxy-propiophenone.
  144         88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
  145         89. 3,4-Methylenedioxy-propiophenone-2-oxime.
  146         90. 3,4-Methylenedioxy-N-acetylcathinone.
  147         91. 3,4-Methylenedioxy-N-acetylmethcathinone.
  148         92. 3,4-Methylenedioxy-N-acetylethcathinone.
  149         93. Bromomethcathinone.
  150         94. Buphedrone (alpha-Methylamino-butyrophenone).
  151         95. Eutylone (3,4-Methylenedioxy-alpha
  152  ethylaminobutyrophenone).
  153         96. Dimethylcathinone.
  154         97. Dimethylmethcathinone.
  155         98. Pentylone (3,4-Methylenedioxy-alpha
  156  methylaminovalerophenone).
  157         99. MDPPP (3,4-Methylenedioxy-alpha
  158  pyrrolidinopropiophenone).
  159         100. MDPBP (3,4-Methylenedioxy-alpha
  160  pyrrolidinobutyrophenone).
  161         101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  162         102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
  163         103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  164  (Benocyclidine).
  165         104. F-MABP (Fluoromethylaminobutyrophenone).
  166         105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
  167         106. Et-PBP (Ethylpyrrolidinobutyrophenone).
  168         107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  169         108. Me-EABP (Methylethylaminobutyrophenone).
  170         109. Etizolam.
  171         110. PPP (Pyrrolidinopropiophenone).
  172         111. PBP (Pyrrolidinobutyrophenone).
  173         112. PVP (Pyrrolidinovalerophenone) or
  174  (Pyrrolidinopentiophenone).
  175         113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
  176         114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  177         115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  178         116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  179         117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  180         118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  181         119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  182         120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  183         121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  184  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  185         122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  186         123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  187         124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  188         125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  189         126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  190         127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  191         128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  192         129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  193         130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  194  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  195  ol).
  196         131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
  197  2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
  198  methanol).
  199         132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
  200  methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
  201  1,4-dione).
  202         133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
  203         134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
  204  undecanamide).
  205         135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
  206  undecanamide).
  207         136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
  208  methyloctan-2-yl)phenol).
  209         137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  210         138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
  211         139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  212         140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2
  213  methoxyphenylacetyl)indole).
  214         141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
  215  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  216  naphthalenylmethanone).
  217         142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
  218  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  219  naphthalenylmethanone).
  220         143. Pentedrone (alpha-Methylaminovalerophenone).
  221         144. Fluoroamphetamine.
  222         145. Fluoromethamphetamine.
  223         146. Methoxetamine.
  224         147. Methiopropamine.
  225         148. Methylbuphedrone (Methyl-alpha
  226  methylaminobutyrophenone).
  227         149. APB ((2-Aminopropyl)benzofuran).
  228         150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
  229         151. UR-144 (1-Pentyl-3-(2,2,3,3
  230  tetramethylcyclopropanoyl)indole).
  231         152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  232  tetramethylcyclopropanoyl)indole).
  233         153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  234  tetramethylcyclopropanoyl)indole).
  235         154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  236         155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  237  iodobenzoyl)indole).
  238         156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  239  carboxamide).
  240         157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
  241  cyclohexylcarbamate).
  242         158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
  243  cyclohexyl ester).
  244         159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
  245  benzoxazin-4-one).
  246         160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  247         161. 2C-H (2,5-Dimethoxyphenethylamine).
  248         162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  249         163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  250         164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  251  methoxybenzyl)]phenethylamine).
  252         165. MDMA (3,4-Methylenedioxymethamphetamine).
  253         166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  254         167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  255  carboxylate).
  256         168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  257  carboxylate).
  258         169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  259  3-carboxamide).
  260         170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  261  pentylindazole-3-carboxamide).
  262         171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  263  (4-fluorobenzyl)indazole-3-carboxamide).
  264         172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  265  1-pentylindazole-3-carboxamide).
  266         173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  267  yl)-1-(fluoropentyl)indole-3-carboxamide).
  268         174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  269  methoxybenzyl)]phenethylamine).
  270         175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  271  methoxybenzyl)]phenethylamine).
  272         176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  273  (cyclohexylmethyl)indazole-3-carboxamide).
  274         177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  275  carboxylate).
  276         178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  277  3-carboxamide).
  278         179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  279  (fluoropentyl)indazole-3-carboxamide).
  280         180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
  281         181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
  282  1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
  283         182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
  284  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  285  hexahydrobenzo[c]chromen-1-ol).
  286         183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
  287  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  288  hexahydrobenzo[c]chromen-1-ol).
  289         184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
  290  6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
  291  diol).
  292         185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
  293  dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
  294  tetrahydro-6aH-benzo[c]chromen-1-ol).
  295         186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
  296  6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
  297         187. MAPB ((2-Methylaminopropyl)benzofuran).
  298         188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
  299         189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
  300         190. Synthetic Cannabinoids.—Unless specifically excepted
  301  or unless listed in another schedule or contained within a
  302  pharmaceutical product approved by the United States Food and
  303  Drug Administration, any material, compound, mixture, or
  304  preparation that contains any quantity of a synthetic
  305  cannabinoid found to be in any of the following chemical class
  306  descriptions, or homologues, nitrogen-heterocyclic analogs,
  307  isomers (including optical, positional, or geometric), esters,
  308  ethers, salts, and salts of homologues, nitrogen-heterocyclic
  309  analogs, isomers, esters, or ethers, whenever the existence of
  310  such homologues, nitrogen-heterocyclic analogs, isomers, esters,
  311  ethers, salts, and salts of isomers, esters, or ethers is
  312  possible within the specific chemical class or designation.
  313  Since nomenclature of these synthetically produced cannabinoids
  314  is not internationally standardized and may continually evolve,
  315  these structures or the compounds of these structures shall be
  316  included under this subparagraph, regardless of their specific
  317  numerical designation of atomic positions covered, if it can be
  318  determined through a recognized method of scientific testing or
  319  analysis that the substance contains properties that fit within
  320  one or more of the following categories:
  321         a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
  322  naturally contained in a plant of the genus Cannabis, the
  323  synthetic equivalents of the substances contained in the plant
  324  or in the resinous extracts of the genus Cannabis, or synthetic
  325  substances, derivatives, and their isomers with similar chemical
  326  structure and pharmacological activity, including, but not
  327  limited to, Delta 9 tetrahydrocannabinols and their optical
  328  isomers, Delta 8 tetrahydrocannabinols and their optical
  329  isomers, Delta 6a,10a tetrahydrocannabinols and their optical
  330  isomers, or any compound containing a tetrahydrobenzo[c]chromene
  331  structure with substitution at either or both the 3-position or
  332  9-position, with or without substitution at the 1-position with
  333  hydroxyl or alkoxy groups, including, but not limited to:
  334         (I) Tetrahydrocannabinol.
  335         (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  336  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  337  ol).
  338         (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  339  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  340  ol).
  341         (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  342  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  343         (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  344  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  345         (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
  346  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  347         (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
  348  dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  349         (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
  350  6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  351         (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
  352  6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  353         (X) Parahexyl.
  354         b. Naphthoylindoles, Naphthoylindazoles,
  355  Naphthoylcarbazoles, Naphthylmethylindoles,
  356  Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
  357  compound containing a naphthoylindole, naphthoylindazole,
  358  naphthoylcarbazole, naphthylmethylindole,
  359  naphthylmethylindazole, or naphthylmethylcarbazole structure,
  360  with or without substitution on the indole, indazole, or
  361  carbazole ring to any extent, whether or not substituted on the
  362  naphthyl ring to any extent, including, but not limited to:
  363         (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  364         (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
  365  naphthoyl)indole).
  366         (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  367         (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
  368         (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  369         (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  370         (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  371         (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
  372         (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
  373         (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  374         (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  375         (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
  376         (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  377         (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
  378  naphthoyl)indole).
  379         (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
  380         (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  381         (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
  382  naphthoyl)indole).
  383         (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
  384         (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  385         (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
  386         (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
  387         (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
  388  naphthylmethyl]indole).
  389         (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
  390  naphthoyl)indole).
  391         (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
  392  naphthoyl)indole).
  393         (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  394  naphthoyl)indole).
  395         (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  396         (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
  397         (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  398         (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
  399         (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
  400         (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
  401  naphthoyl)indole).
  402         (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
  403  naphthoyl)indole).
  404         (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
  405  naphthoyl)indole).
  406         (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
  407  naphthoyl)indole).
  408         (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
  409  naphthoyl)indole).
  410         (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
  411         (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
  412  naphthoyl)indazole).
  413         (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
  414  naphthoyl)indole).
  415         (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
  416  naphthoyl)indole).
  417         (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
  418         (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1
  419  naphthoyl)carbazole).
  420         c. Naphthoylpyrroles.—Any compound containing a
  421  naphthoylpyrrole structure, with or without substitution on the
  422  pyrrole ring to any extent, whether or not substituted on the
  423  naphthyl ring to any extent, including, but not limited to:
  424         (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
  425         (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
  426         (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  427         (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  428         (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  429         (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
  430  naphthoyl)pyrrole).
  431         (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
  432  naphthoyl)pyrrole).
  433         (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
  434  naphthoyl)pyrrole).
  435         (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
  436  naphthoyl)pyrrole).
  437         (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
  438  naphthoyl)pyrrole).
  439         d. Naphthylmethylenindenes.—Any compound containing a
  440  naphthylmethylenindene structure, with or without substitution
  441  at the 3-position of the indene ring to any extent, whether or
  442  not substituted on the naphthyl ring to any extent, including,
  443  but not limited to, JWH-176 (3-Pentyl-1
  444  (naphthylmethylene)indene).
  445         e. Phenylacetylindoles and Phenylacetylindazoles.—Any
  446  compound containing a phenylacetylindole or phenylacetylindazole
  447  structure, with or without substitution on the indole or
  448  indazole ring to any extent, whether or not substituted on the
  449  phenyl ring to any extent, including, but not limited to:
  450         (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
  451         (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  452         (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  453         (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  454         (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  455         (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  456         (VII) Cannabipiperidiethanone.
  457         (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
  458  methoxyphenylacetyl)indole).
  459         f. Cyclohexylphenols.—Any compound containing a
  460  cyclohexylphenol structure, with or without substitution at the
  461  5-position of the phenolic ring to any extent, whether or not
  462  substituted on the cyclohexyl ring to any extent, including, but
  463  not limited to:
  464         (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  465  yl)phenol).
  466         (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
  467  homologue).
  468         (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
  469  methyloctan-2-yl)phenol).
  470         g. Benzoylindoles and Benzoylindazoles.—Any compound
  471  containing a benzoylindole or benzoylindazole structure, with or
  472  without substitution on the indole or indazole ring to any
  473  extent, whether or not substituted on the phenyl ring to any
  474  extent, including, but not limited to:
  475         (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
  476         (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  477         (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  478  iodo-5-nitrobenzoyl)indole).
  479         (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
  480  methoxybenzoyl)indole).
  481         (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  482  iodobenzoyl)indole).
  483         (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  484         (VII) RCS-4 C4 homologue (1-Butyl-3-(4
  485  methoxybenzoyl)indole).
  486         (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
  487  3-(4-methoxybenzoyl)indole).
  488         h. Tetramethylcyclopropanoylindoles and
  489  Tetramethylcyclopropanoylindazoles.—Any compound containing a
  490  tetramethylcyclopropanoylindole or
  491  tetramethylcyclopropanoylindazole structure, with or without
  492  substitution on the indole or indazole ring to any extent,
  493  whether or not substituted on the tetramethylcyclopropyl group
  494  to any extent, including, but not limited to:
  495         (I) UR-144 (1-Pentyl-3-(2,2,3,3
  496  tetramethylcyclopropanoyl)indole).
  497         (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  498  tetramethylcyclopropanoyl)indole).
  499         (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  500  tetramethylcyclopropanoyl)indole).
  501         (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
  502  tetramethylcyclopropanoyl)indole).
  503         (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
  504  tetramethylcyclopropanoyl)indole).
  505         (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
  506  tetramethylcyclopropanoyl)indole).
  507         (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
  508  tetramethylcyclopropanoyl)indole).
  509         (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
  510  tetramethylcyclopropanoyl)indazole).
  511         (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
  512  tetramethylcyclopropanoyl)indole).
  513         (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
  514  tetramethylcyclopropanoyl)indole).
  515         i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
  516  carboxamides, and Adamantylindazole carboxamides.—Any compound
  517  containing an adamantoyl indole, adamantoyl indazole, adamantyl
  518  indole carboxamide, or adamantyl indazole carboxamide structure,
  519  with or without substitution on the indole or indazole ring to
  520  any extent, whether or not substituted on the adamantyl ring to
  521  any extent, including, but not limited to:
  522         (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  523         (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  524  3-carboxamide).
  525         (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  526  carboxamide).
  527         (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1
  528  adamantoyl)indole).
  529         (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
  530         (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
  531         (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1
  532  adamantoyl)indole).
  533         j. Quinolinylindolecarboxylates,
  534  Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
  535  and Quinolinylindazolecarboxamides.—Any compound containing a
  536  quinolinylindole carboxylate, quinolinylindazole carboxylate,
  537  isoquinolinylindole carboxylate, isoquinolinylindazole
  538  carboxylate, quinolinylindole carboxamide, quinolinylindazole
  539  carboxamide, isoquinolinylindole carboxamide, or
  540  isoquinolinylindazole carboxamide structure, with or without
  541  substitution on the indole or indazole ring to any extent,
  542  whether or not substituted on the quinoline or isoquinoline ring
  543  to any extent, including, but not limited to:
  544         (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  545         (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  546  carboxylate).
  547         (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  548  carboxylate).
  549         (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  550  carboxylate).
  551         (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
  552         (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
  553  3-carboxylate).
  554         (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
  555  3-carboxylate).
  556         (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
  557         (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
  558  carboxamide).
  559         k. Naphthylindolecarboxylates and
  560  Naphthylindazolecarboxylates.—Any compound containing a
  561  naphthylindole carboxylate or naphthylindazole carboxylate
  562  structure, with or without substitution on the indole or
  563  indazole ring to any extent, whether or not substituted on the
  564  naphthyl ring to any extent, including, but not limited to:
  565         (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
  566  carboxylate).
  567         (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
  568  carboxylate).
  569         (III) Fluoro SDB-005 (1-Naphthalenyl 1
  570  (fluoropentyl)indazole-3-carboxylate).
  571         (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
  572  carboxylate).
  573         (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
  574  carboxylate).
  575         l. Naphthylindole carboxamides and Naphthylindazole
  576  carboxamides.—Any compound containing a naphthylindole
  577  carboxamide or naphthylindazole carboxamide structure, with or
  578  without substitution on the indole or indazole ring to any
  579  extent, whether or not substituted on the naphthyl ring to any
  580  extent, including, but not limited to:
  581         (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
  582         (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  583  3-carboxamide).
  584         (III) Chloro-NNEI (N-Naphthalen-1-yl 1
  585  (chloropentyl)indole-3-carboxamide).
  586         (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
  587  carboxamide).
  588         (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
  589  (fluoropentyl)indazole-3-carboxamide).
  590         m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
  591  indazole carboxamides, Alkylcarbonyl indole carboxylates, and
  592  Alkylcarbonyl indazole carboxylates.—Any compound containing an
  593  alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
  594  1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
  595  phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
  596  indole carboxamide, indazole carboxamide, indole carboxylate, or
  597  indazole carboxylate, with or without substitution on the indole
  598  or indazole ring to any extent, whether or not substituted on
  599  the alkylcarbonyl group to any extent, including, but not
  600  limited to:
  601         (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
  602  pentylindole-3-carboxamide).
  603         (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  604  yl)-1-(fluoropentyl)indole-3-carboxamide).
  605         (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  606  (fluoropentyl)indole-3-carboxamide).
  607         (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  608  pentylindazole-3-carboxamide).
  609         (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
  610  1-(fluoropentyl)indazole-3-carboxamide).
  611         (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  612  1-pentylindazole-3-carboxamide).
  613         (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
  614  oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
  615         (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  616  (4-fluorobenzyl)indazole-3-carboxamide).
  617         (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  618  yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  619         (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  620  (cyclohexylmethyl)indazole-3-carboxamide).
  621         (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  622  (cyclohexylmethyl)indazole-3-carboxamide).
  623         (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  624  yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  625         (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  626  pentylindazole-3-carboxamide).
  627         (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  628  (fluoropentyl)indazole-3-carboxamide).
  629         (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
  630  fluorobenzyl)indazole-3-carboxamide).
  631         (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  632  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  633         (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  634  2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  635         (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  636  2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
  637         (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  638  fluoropentyl)indole-3-carboxamide).
  639         (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  640  fluoropentyl)indazole-3-carboxamide).
  641         (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
  642  (cyclohexylmethyl)indazole-3-carboxamide).
  643         (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
  644  fluorobenzyl)indazole-3-carboxamide).
  645         (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  646  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
  647         n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
  648  Any compound containing a N-(2-phenylpropan-2-yl) indole
  649  carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
  650  structure, with or without substitution on the indole or
  651  indazole ring to any extent, whether or not substituted on the
  652  phenyl ring of the cumyl group to any extent, including, but not
  653  limited to:
  654         (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
  655  carboxamide).
  656         (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
  657  (fluoropentyl)indole-3-carboxamide).
  658         o. Other Synthetic Cannabinoids.—Any material, compound,
  659  mixture, or preparation that contains any quantity of a
  660  Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
  661         (I) With or without modification or replacement of a
  662  carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
  663  between either two core rings, or linkage between a core ring
  664  and group structure, with or without the addition of a carbon or
  665  replacement of a carbon;
  666         (II) With or without replacement of a core ring or group
  667  structure, whether or not substituted on the ring or group
  668  structures to any extent; and
  669         (III) Is a cannabinoid receptor agonist, unless
  670  specifically excepted or unless listed in another schedule or
  671  contained within a pharmaceutical product approved by the United
  672  States Food and Drug Administration.
  673         191. Substituted Cathinones.—Unless specifically excepted,
  674  listed in another schedule, or contained within a pharmaceutical
  675  product approved by the United States Food and Drug
  676  Administration, any material, compound, mixture, or preparation,
  677  including its salts, isomers, esters, or ethers, and salts of
  678  isomers, esters, or ethers, whenever the existence of such salts
  679  is possible within any of the following specific chemical
  680  designations:
  681         a. Any compound containing a 2-amino-1-phenyl-1-propanone
  682  structure;
  683         b. Any compound containing a 2-amino-1-naphthyl-1-propanone
  684  structure; or
  685         c. Any compound containing a 2-amino-1-thiophenyl-1
  686  propanone structure,
  687  
  688  whether or not the compound is further modified:
  689         (I) With or without substitution on the ring system to any
  690  extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
  691  haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
  692  dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
  693  substituents;
  694         (II) With or without substitution at the 3-propanone
  695  position with an alkyl substituent or removal of the methyl
  696  group at the 3-propanone position;
  697         (III) With or without substitution at the 2-amino nitrogen
  698  atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
  699  not further substituted in the ring system; or
  700         (IV) With or without inclusion of the 2-amino nitrogen atom
  701  in a cyclic structure, including, but not limited to:
  702         (A) Methcathinone.
  703         (B) Ethcathinone.
  704         (C) Methylone (3,4-Methylenedioxymethcathinone).
  705         (D) 2,3-Methylenedioxymethcathinone.
  706         (E) MDPV (3,4-Methylenedioxypyrovalerone).
  707         (F) Methylmethcathinone.
  708         (G) Methoxymethcathinone.
  709         (H) Fluoromethcathinone.
  710         (I) Methylethcathinone.
  711         (J) Butylone (3,4-Methylenedioxy-alpha
  712  methylaminobutyrophenone).
  713         (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
  714         (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
  715         (M) Naphyrone (Naphthylpyrovalerone).
  716         (N) Bromomethcathinone.
  717         (O) Buphedrone (alpha-Methylaminobutyrophenone).
  718         (P) Eutylone (3,4-Methylenedioxy-alpha
  719  ethylaminobutyrophenone).
  720         (Q) Dimethylcathinone.
  721         (R) Dimethylmethcathinone.
  722         (S) Pentylone (3,4-Methylenedioxy-alpha
  723  methylaminovalerophenone).
  724         (T) Pentedrone (alpha-Methylaminovalerophenone).
  725         (U) MDPPP (3,4-Methylenedioxy-alpha
  726  pyrrolidinopropiophenone).
  727         (V) MDPBP (3,4-Methylenedioxy-alpha
  728  pyrrolidinobutyrophenone).
  729         (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
  730         (X) PPP (Pyrrolidinopropiophenone).
  731         (Y) PVP (Pyrrolidinovalerophenone) or
  732  (Pyrrolidinopentiophenone).
  733         (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  734         (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
  735         (BB) F-MABP (Fluoromethylaminobutyrophenone).
  736         (CC) Me-EABP (Methylethylaminobutyrophenone).
  737         (DD) PBP (Pyrrolidinobutyrophenone).
  738         (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
  739         (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
  740         (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  741         (HH) Dimethylone (3,4-Methylenedioxy-N,N
  742  dimethylcathinone).
  743         (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
  744         (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
  745         (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
  746         (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
  747         (MM) Methylbuphedrone (Methyl-alpha
  748  methylaminobutyrophenone).
  749         (NN) Methyl-alpha-methylaminohexanophenone.
  750         (OO) N-Ethyl-N-methylcathinone.
  751         (PP) PHP (Pyrrolidinohexanophenone).
  752         (QQ) PV8 (Pyrrolidinoheptanophenone).
  753         (RR) Chloromethcathinone.
  754         (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
  755         192. Substituted Phenethylamines.—Unless specifically
  756  excepted or unless listed in another schedule, or contained
  757  within a pharmaceutical product approved by the United States
  758  Food and Drug Administration, any material, compound, mixture,
  759  or preparation, including its salts, isomers, esters, or ethers,
  760  and salts of isomers, esters, or ethers, whenever the existence
  761  of such salts is possible within any of the following specific
  762  chemical designations, any compound containing a phenethylamine
  763  structure, without a beta-keto group, and without a benzyl group
  764  attached to the amine group, whether or not the compound is
  765  further modified with or without substitution on the phenyl ring
  766  to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
  767  halide, fused alkylenedioxy, fused furan, fused benzofuran,
  768  fused dihydrofuran, or fused tetrahydropyran substituents,
  769  whether or not further substituted on a ring to any extent, with
  770  or without substitution at the alpha or beta position by any
  771  alkyl substituent, with or without substitution at the nitrogen
  772  atom, and with or without inclusion of the 2-amino nitrogen atom
  773  in a cyclic structure, including, but not limited to:
  774         a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
  775         b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  776         c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  777         d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  778         e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  779         f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  780         g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  781         h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  782         i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  783         j. 2C-H (2,5-Dimethoxyphenethylamine).
  784         k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  785         l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  786         m. MDMA (3,4-Methylenedioxymethamphetamine).
  787         n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
  788  Methylenedioxy-N-methylbutanamine).
  789         o. MDA (3,4-Methylenedioxyamphetamine).
  790         p. 2,5-Dimethoxyamphetamine.
  791         q. Fluoroamphetamine.
  792         r. Fluoromethamphetamine.
  793         s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
  794         t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
  795         u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  796         v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
  797         w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  798         x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
  799         y. PMA (4-Methoxyamphetamine).
  800         z. N-Ethylamphetamine.
  801         aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
  802         bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
  803         cc. PMMA (4-Methoxymethamphetamine).
  804         dd. N,N-Dimethylamphetamine.
  805         ee. 3,4,5-Trimethoxyamphetamine.
  806         ff. 4-APB (4-(2-Aminopropyl)benzofuran).
  807         gg. 5-APB (5-(2-Aminopropyl)benzofuran).
  808         hh. 6-APB (6-(2-Aminopropyl)benzofuran).
  809         ii. 7-APB (7-(2-Aminopropyl)benzofuran).
  810         jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  811         kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  812         ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  813         mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  814         nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
  815         oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
  816         pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
  817         qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
  818         rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
  819         ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
  820  dihydrobenzofuran),
  821  
  822  which does not include phenethylamine, mescaline as described in
  823  subparagraph 20., substituted cathinones as described in
  824  subparagraph 191., N-Benzyl phenethylamine compounds as
  825  described in subparagraph 193., or methamphetamine as described
  826  in subparagraph (2)(c)4.
  827         193. N-Benzyl Phenethylamine Compounds.—Unless specifically
  828  excepted or unless listed in another schedule, or contained
  829  within a pharmaceutical product approved by the United States
  830  Food and Drug Administration, any material, compound, mixture,
  831  or preparation, including its salts, isomers, esters, or ethers,
  832  and salts of isomers, esters, or ethers, whenever the existence
  833  of such salts is possible within any of the following specific
  834  chemical designations, any compound containing a phenethylamine
  835  structure without a beta-keto group, with substitution on the
  836  nitrogen atom of the amino group with a benzyl substituent, with
  837  or without substitution on the phenyl or benzyl ring to any
  838  extent with alkyl, alkoxy, thio, alkylthio, halide, fused
  839  alkylenedioxy, fused furan, fused benzofuran, or fused
  840  tetrahydropyran substituents, whether or not further substituted
  841  on a ring to any extent, with or without substitution at the
  842  alpha position by any alkyl substituent, including, but not
  843  limited to:
  844         a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  845  methoxybenzyl)]phenethylamine).
  846         b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
  847  hydroxybenzyl)]phenethylamine).
  848         c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
  849  fluorobenzyl)]phenethylamine).
  850         d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
  851  methylenedioxybenzyl)]phenethylamine).
  852         e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  853  methoxybenzyl)]phenethylamine).
  854         f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
  855  hydroxybenzyl)]phenethylamine).
  856         g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
  857  fluorobenzyl)]phenethylamine).
  858         h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
  859  methylenedioxybenzyl)]phenethylamine).
  860         i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
  861  methoxybenzyl)]phenethylamine).
  862         j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
  863  methoxybenzyl)]phenethylamine).
  864         k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
  865  methoxybenzyl)]phenethylamine).
  866         l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  867  methoxybenzyl)]phenethylamine).
  868         m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
  869  hydroxybenzyl)]phenethylamine).
  870         n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
  871  fluorobenzyl)]phenethylamine).
  872         o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
  873  methylenedioxybenzyl)]phenethylamine).
  874         p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
  875  methoxybenzyl)]phenethylamine).
  876         q. 25H-NBOH (2,5-Dimethoxy-[N-(2
  877  hydroxybenzyl)]phenethylamine).
  878         r. 25H-NBF (2,5-Dimethoxy-[N-(2
  879  fluorobenzyl)]phenethylamine).
  880         s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
  881  methoxybenzyl)]phenethylamine),
  882  
  883  which does not include substituted cathinones as described in
  884  subparagraph 191.
  885         194. Substituted Tryptamines.—Unless specifically excepted
  886  or unless listed in another schedule, or contained within a
  887  pharmaceutical product approved by the United States Food and
  888  Drug Administration, any material, compound, mixture, or
  889  preparation containing a 2-(1H-indol-3-yl)ethanamine, for
  890  example tryptamine, structure with or without mono- or di
  891  substitution of the amine nitrogen with alkyl or alkenyl groups,
  892  or by inclusion of the amino nitrogen atom in a cyclic
  893  structure, whether or not substituted at the alpha position with
  894  an alkyl group, whether or not substituted on the indole ring to
  895  any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
  896  groups, including, but not limited to:
  897         a. Alpha-Ethyltryptamine.
  898         b. Bufotenine.
  899         c. DET (Diethyltryptamine).
  900         d. DMT (Dimethyltryptamine).
  901         e. MET (N-Methyl-N-ethyltryptamine).
  902         f. DALT (N,N-Diallyltryptamine).
  903         g. EiPT (N-Ethyl-N-isopropyltryptamine).
  904         h. MiPT (N-Methyl-N-isopropyltryptamine).
  905         i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  906         j. 5-Hydroxy-N-methyltryptamine.
  907         k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  908         l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  909         m. Methyltryptamine.
  910         n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  911         o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  912         p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  913         q. DiPT (N,N-Diisopropyltryptamine).
  914         r. DPT (N,N-Dipropyltryptamine).
  915         s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  916         t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  917         u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
  918         v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
  919         w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
  920         x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
  921         y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
  922  isopropyltryptamine).
  923         z. Methyl-alpha-ethyltryptamine.
  924         aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
  925  
  926  which does not include tryptamine, psilocyn as described in
  927  subparagraph 34., or psilocybin as described in subparagraph 33.
  928         195. Substituted Phenylcyclohexylamines.—Unless
  929  specifically excepted or unless listed in another schedule, or
  930  contained within a pharmaceutical product approved by the United
  931  States Food and Drug Administration, any material, compound,
  932  mixture, or preparation containing a phenylcyclohexylamine
  933  structure, with or without any substitution on the phenyl ring,
  934  any substitution on the cyclohexyl ring, any replacement of the
  935  phenyl ring with a thiophenyl or benzothiophenyl ring, with or
  936  without substitution on the amine with alkyl, dialkyl, or alkoxy
  937  substituents, inclusion of the nitrogen in a cyclic structure,
  938  or any combination of the above, including, but not limited to:
  939         a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  940  (Benocyclidine).
  941         b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
  942  of phencyclidine).
  943         c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
  944  analog of phencyclidine).
  945         d. PCPr (Phenylcyclohexylpropylamine).
  946         e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
  947  analog of phencyclidine).
  948         f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
  949         g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
  950         h. Methoxetamine.
  951         i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
  952         j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
  953         k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
  954         l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
  955         m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
  956         n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
  957         o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
  958         p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
  959         q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
  960         r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
  961         196. CBD (Cannabidiol).
  962         Section 2. This act shall take effect July 1, 2017.